Mutant Chimeric Proteins [mutantní chimérické proteiny]
- Terms
-
Chimeric Proteins, Mutant
Hybrid Proteins, Mutant
Mutant Hybrid Proteins
Proteins produced from GENES that have mutated by the fusing of protein coding regions of more than one gene. Such hybrid proteins are responsible for some instances of ANTIBIOTIC RESISTANCE and defective biological processes such as NEOPLASMS.
- Annotation
- do not confuse with CHIMERIC PROTEINS, RECOMBINANT see RECOMBINANT FUSION PROTEINS or CHIMERIC PROTEINS, ONCOGENE see ONCOGENE PROTEINS, FUSION
- DUI
- D050506 MeSH Browser
- CUI
- M0475666
- History note
- 2006
- Public note
- 2006
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification 1
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 1
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
CFH-CFHL1 protein, human Chemical MeSH Browser
CSB-PGBD3 fusion protein, human Chemical MeSH Browser
INS-IGF2 protein, human Chemical MeSH Browser
Jingwei protein, Drosophila Chemical MeSH Browser
TRIM5-cyclophilin A protein, Macaca nemestrina Chemical MeSH Browser
ZEB2-BCL11B fusion protein, human Chemical MeSH Browser
chimeric Pvt-1a Ig-Ck Chemical MeSH Browser